Contact this trialFirst, we need to learn more about you.
PD-L1 Inhibitor
MT-6402 for Solid Cancers
Recruiting1 awardPhase 1
Lebanon, New Hampshire
This trial is for a new cancer treatment called MT-6402. It will test how well it works and what side effects it has in people with advanced solid cancer that is positive for PD-L1.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.